These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31122493)

  • 1. Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
    Ford GA; Bhakta BB; Cozens A; Hartley S; Holloway I; Meads D; Pearn J; Ruddock S; Sackley CM; Saloniki EC; Santorelli G; Walker MF; Farrin AJ
    Lancet Neurol; 2019 Jun; 18(6):530-538. PubMed ID: 31122493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke.
    Bhakta BB; Hartley S; Holloway I; Couzens JA; Ford GA; Meads D; Sackley CM; Walker MF; Ruddock SP; Farrin AJ
    Trials; 2014 Aug; 15():316. PubMed ID: 25106447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study.
    Scheidtmann K; Fries W; Müller F; Koenig E
    Lancet; 2001 Sep; 358(9284):787-90. PubMed ID: 11564483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of GABA
    Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
    Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of non-immersive virtual reality exercising in stroke rehabilitation (EVREST): a randomised, multicentre, single-blind, controlled trial.
    Saposnik G; Cohen LG; Mamdani M; Pooyania S; Ploughman M; Cheung D; Shaw J; Hall J; Nord P; Dukelow S; Nilanont Y; De Los Rios F; Olmos L; Levin M; Teasell R; Cohen A; Thorpe K; Laupacis A; Bayley M;
    Lancet Neurol; 2016 Sep; 15(10):1019-27. PubMed ID: 27365261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.
    Goldstein LB; Lennihan L; Rabadi MJ; Good DC; Reding MJ; Dromerick AW; Samsa GP; Pura J
    JAMA Neurol; 2018 Dec; 75(12):1494-1501. PubMed ID: 30167675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
    Hill MD; Goyal M; Menon BK; Nogueira RG; McTaggart RA; Demchuk AM; Poppe AY; Buck BH; Field TS; Dowlatshahi D; van Adel BA; Swartz RH; Shah RA; Sauvageau E; Zerna C; Ospel JM; Joshi M; Almekhlafi MA; Ryckborst KJ; Lowerison MW; Heard K; Garman D; Haussen D; Cutting SM; Coutts SB; Roy D; Rempel JL; Rohr AC; Iancu D; Sahlas DJ; Yu AYX; Devlin TG; Hanel RA; Puetz V; Silver FL; Campbell BCV; Chapot R; Teitelbaum J; Mandzia JL; Kleinig TJ; Turkel-Parrella D; Heck D; Kelly ME; Bharatha A; Bang OY; Jadhav A; Gupta R; Frei DF; Tarpley JW; McDougall CG; Holmin S; Rha JH; Puri AS; Camden MC; Thomalla G; Choe H; Phillips SJ; Schindler JL; Thornton J; Nagel S; Heo JH; Sohn SI; Psychogios MN; Budzik RF; Starkman S; Martin CO; Burns PA; Murphy S; Lopez GA; English J; Tymianski M;
    Lancet; 2020 Mar; 395(10227):878-887. PubMed ID: 32087818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial.
    LeWitt PA; Hauser RA; Pahwa R; Isaacson SH; Fernandez HH; Lew M; Saint-Hilaire M; Pourcher E; Lopez-Manzanares L; Waters C; Rudzínska M; Sedkov A; Batycky R; Oh C;
    Lancet Neurol; 2019 Feb; 18(2):145-154. PubMed ID: 30663606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa improves procedural motor learning in chronic stroke patients.
    Rösser N; Heuschmann P; Wersching H; Breitenstein C; Knecht S; Flöel A
    Arch Phys Med Rehabil; 2008 Sep; 89(9):1633-41. PubMed ID: 18760148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
    Palmer R; Dimairo M; Cooper C; Enderby P; Brady M; Bowen A; Latimer N; Julious S; Cross E; Alshreef A; Harrison M; Bradley E; Witts H; Chater T
    Lancet Neurol; 2019 Sep; 18(9):821-833. PubMed ID: 31397288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial.
    Langhorne P; Wu O; Rodgers H; Ashburn A; Bernhardt J
    Health Technol Assess; 2017 Sep; 21(54):1-120. PubMed ID: 28967376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
    Shoamanesh A; Mundl H; Smith EE; Masjuan J; Milanov I; Hirano T; Agafina A; Campbell B; Caso V; Mas JL; Dong Q; Turcani P; Christensen H; Ferro JM; Veltkamp R; Mikulik R; De Marchis GM; Robinson T; Lemmens R; Stepien A; Greisenegger S; Roine R; Csiba L; Khatri P; Coutinho J; Lindgren AG; Demchuk AM; Colorado P; Kirsch B; Neumann C; Heenan L; Xu L; Connolly SJ; Hart RG;
    Lancet; 2022 Sep; 400(10357):997-1007. PubMed ID: 36063821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
    Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
    EFFECTS Trial Collaboration
    Lancet Neurol; 2020 Aug; 19(8):661-669. PubMed ID: 32702335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.
    Ginsberg MD; Palesch YY; Hill MD; Martin RH; Moy CS; Barsan WG; Waldman BD; Tamariz D; Ryckborst KJ;
    Lancet Neurol; 2013 Nov; 12(11):1049-58. PubMed ID: 24076337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial.
    AVERT Trial Collaboration group
    Lancet; 2015 Jul; 386(9988):46-55. PubMed ID: 25892679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.